Home › Cardiomyopathy

Cardiomyopathy clinical trials recruiting in the U.S.

44 studies for Cardiomyopathy are recruiting participants at sites across the United States.

Cardiomyopathy is a disease that causes the heart to become enlarged, thick, or stiff. Read about the different types, their symptoms, and treatments.

Cities with the most studies

• New York City, NY10 studies
• Boston, MA9 studies
• San Diego, CA8 studies
• Washington, DC8 studies
• Rochester, MN8 studies
• Baltimore, MD7 studies
• Dallas, TX6 studies
• St. Louis, MO6 studies
• Philadelphia, PA6 studies
• Charleston, SC6 studies
• Indianapolis, IN6 studies
• Richmond, VA6 studies
• Houston, TX5 studies
• Detroit, MI5 studies
• Mountain View, CA5 studies
• Durham, NC5 studies
• Chicago, IL5 studies
• Nashville, TN4 studies
• Atlanta, GA4 studies
• Cleveland, OH4 studies
• Seattle, WA4 studies
• Arlington, VA4 studies
• New Haven, CT3 studies
• Ann Arbor, MI3 studies
• Aurora, CO3 studies
• Los Angeles, CA3 studies
• Pittsburgh, PA3 studies
• Rochester, NY3 studies
• Columbus, OH3 studies
• Kansas City, MO3 studies
• Jacksonville, FL3 studies
• Portland, OR3 studies
• Salt Lake City, UT3 studies

By state

• Arizona4 studies
• California14 studies
• Colorado4 studies
• Connecticut4 studies
• District of Columbia7 studies
• Florida8 studies
• Georgia5 studies
• Illinois5 studies
• Indiana6 studies
• Kansas3 studies
• Maryland9 studies
• Massachusetts9 studies
• Michigan7 studies
• Minnesota8 studies
• Missouri9 studies
• New York14 studies
• North Carolina7 studies
• Ohio6 studies
• Oregon3 studies
• Pennsylvania6 studies
• South Carolina6 studies
• Tennessee5 studies
• Texas9 studies
• Utah3 studies
• Virginia8 studies
• Washington4 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.